VERSO BIOSENSE LIMITED - ABINGDON
Company Profile | Company Filings |
Overview
VERSO BIOSENSE LIMITED is a Private Limited Company from ABINGDON UNITED KINGDOM and has the status: Active.
VERSO BIOSENSE LIMITED was incorporated 14 years ago on 22/06/2009 and has the registered number: 06939964. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
VERSO BIOSENSE LIMITED was incorporated 14 years ago on 22/06/2009 and has the registered number: 06939964. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
VERSO BIOSENSE LIMITED - ABINGDON
This company is listed in the following categories:
72190 - Other research and experimental development on natural sciences and engineering
72190 - Other research and experimental development on natural sciences and engineering
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
115B INNOVATION DRIVE
MILTON PARK
ABINGDON
OXFORDSHIRE
OX14 4RZ
UNITED KINGDOM
This Company Originates in : United Kingdom
Previous trading names include:
VIVOPLEX MEDICAL LIMITED (until 22/02/2021)
VIVOPLEX MEDICAL LIMITED (until 22/02/2021)
FIDELITY TECHNOLOGIES LTD (until 06/10/2017)
FIDELITY DATA NETWORKS LIMITED (until 18/12/2014)
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
22/06/2023 | 06/07/2024 |
Map
115B INNOVATION DRIVE
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
CHARLES EDWARD DICKSON | Feb 1982 | British | Director | 2017-04-18 | CURRENT |
DR CHRISTOPHER JOHN DICKSON | Sep 1959 | British | Director | 2014-07-23 | CURRENT |
MR ALEXANDER CHARLES WALLACE SNOW | Apr 1969 | British | Director | 2020-09-02 | CURRENT |
PROF HYWEL MORGAN | Jun 1960 | British | Director | 2017-11-28 | CURRENT |
DR JOSEPH JOHN CEFAI | Apr 1963 | British | Director | 2023-04-03 | CURRENT |
PROFESSOR NICHOLAS STEPHEN MACKLON | Feb 1963 | British | Director | 2017-11-28 | CURRENT |
DR YING CHING CHEONG | May 1972 | Singaporean | Director | 2017-11-28 | CURRENT |
SUSAN JANE CLARKE | Secretary | 2013-01-22 UNTIL 2014-04-01 | RESIGNED | ||
JOANNA SMART | Apr 1979 | British | Director | 2017-11-28 UNTIL 2020-09-28 | RESIGNED |
DR YING CHING CHEONG | May 1972 | Singaporean | Director | 2014-12-19 UNTIL 2015-11-23 | RESIGNED |
MR ROBERT JAMES CONDON | Apr 1949 | British | Director | 2009-06-22 UNTIL 2010-03-01 | RESIGNED |
PROF HYWEL MORGAN | Jun 1960 | British | Director | 2014-12-19 UNTIL 2015-11-23 | RESIGNED |
PROFESSOR NICHOLAS STEPHEN MACKLON | Feb 1963 | British | Director | 2015-04-07 UNTIL 2015-11-23 | RESIGNED |
THOMAS SANFORD JEWETT | Jan 1958 | United States | Director | 2009-11-01 UNTIL 2011-06-21 | RESIGNED |
DR SHILONG LU | Jan 1985 | Chinese | Director | 2014-07-23 UNTIL 2019-11-26 | RESIGNED |
MR CHARLES EDWARD DICKSON | Feb 1982 | British | Director | 2010-02-03 UNTIL 2011-11-13 | RESIGNED |
MRS DAVINA MARGARET DICKSON | Apr 1956 | British | Director | 2014-09-01 UNTIL 2017-11-28 | RESIGNED |
MRS SUSAN JANE CLARKE | Sep 1950 | British | Director | 2011-09-27 UNTIL 2013-01-16 | RESIGNED |
MR ROBERT JAMES CONDON | Apr 1949 | British | Director | 2013-01-22 UNTIL 2015-06-11 | RESIGNED |
DAVINA MARGARET DICKSON | Secretary | 2014-09-01 UNTIL 2023-04-03 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Verso Biosense Group Limited | 2017-03-31 | Abingdon |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
|
Mr Christopher John Dickson | 2016-04-06 - 2017-03-31 | 9/1959 | Preston Lancashire |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Mrs Davina Margaret Dickson | 2016-04-06 - 2017-03-31 | 4/1956 | Preston Lancashire |
Ownership of shares 50 to 75 percent Voting rights 50 to 75 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
VERSO_BIOSENSE_LIMITED_(P - Accounts | 2023-09-28 | 31-12-2022 | £28,782 Cash £-6,670,189 equity |
VERSO_BIOSENSE_LIMITED_(P - Accounts | 2022-10-04 | 31-12-2021 | £1,995 Cash £-5,599,329 equity |
VERSO_BIOSENSE_LIMITED_(P - Accounts | 2021-09-28 | 31-12-2020 | £66,393 Cash £-4,686,166 equity |
VIVOPLEX_MEDICAL_LIMITED - Accounts | 2020-07-24 | 31-12-2019 | £1,357 Cash £-3,500,175 equity |
VIVOPLEX_MEDICAL_LIMITED - Accounts | 2019-09-20 | 31-12-2018 | £18,501 Cash £-1,982,746 equity |
VIVOPLEX_MEDICAL_LIMITED_ - Accounts | 2018-10-13 | 31-12-2017 | £5,422 Cash £-1,029,954 equity |
FIDELITY_TECHNOLOGIES_LIM - Accounts | 2016-09-20 | 21-12-2015 | £20,376 Cash £-108,521 equity |
FIDELITY_TECHNOLGIES_LIMI - Accounts | 2016-03-31 | 21-12-2014 | £-45,405 equity |